Clinical Genomics, Second Edition is a comprehensive, practical reference [AN1] designed specifically for laboratory directors, clinical medical directors, and genomic medicine professionals. Edited by renowned genomic pathology leaders Kulkarni and Roy, this updated edition offers clear guidance on the current technical, bioinformatic, clinical, regulatory, and reimbursement considerations involved in implementing next-generation sequencing technologies within clinical molecular diagnostic laboratories.
Structured for ease of reference, this book covers targeted gene sequencing methods, whole exome/genome approaches, emerging technologies such as long-read sequencing, and critical considerations for assay validation. Detailed sections address bioinformatics workflows, variant detection and interpretation methodologies, integration with clinical informatics systems, and essential IT infrastructure, including cloud-based solutions.
This book also thoroughly addresses practical topics essential to laboratory management, such as regulatory compliance, ethical frameworks, billing strategies, and reimbursement paradigms, helping directors navigate the evolving landscape of genomic diagnostics.
Inhaltsverzeichnis
Section I: Methods< BR> 1. Overview of Technical Aspects and Chemistries of Next-Generation Sequencing< BR> 2. Targeted Hybrid Capture Methods< BR> 3. Amplification-Based Methods< BR> 4. Emerging DNA Sequencing Technologies< BR> 5. Transcriptomics, RNA-Sequencing and Methylome Analysis< BR> < BR> Section II: Bioinformatics< BR> 6. Base Calling, Read Mapping, and Coverage Analysis< BR> 7. Single Nucleotide Variant Detection Using Next Generation Sequencing< BR> 8. Insertions and Deletions (Indels)< BR> 9. Translocation Detection Using Next-Generation Sequencing< BR> 10. Copy Number Variant Detection Using Next-Generation Sequencing< BR> 11. Reference Databases for Disease Associations< BR> 12. Reporting of Clinical Genomics Test Results< BR> 13. Reporting Software< BR> 14. Constitutional Diseases: Target enrichment strategies for Targeted gene sequencing panels< BR> 15. Targeted Hybrid Capture for Inherited Disease Panels< BR> 16. Constitutional Disorders: Whole Exome and Whole Genome Sequencing< BR> 17. Somatic Diseases (Cancer): Amplification-Based Next-Generation Sequencing< BR> 18. Targeted Hybrid-Capture for Somatic Mutation Detection in the Clinic< BR> 19. Somatic Diseases (Cancer): Whole Exome and Whole Genome Sequencing< BR> 20. Assay Validation< BR> 21. Regulatory Considerations Related to Clinical Next Generation Sequencing< BR> 22. Genomic Reference Materials for Clinical Applications< BR> 23. Ethical Challenges in Clinical Genomics< BR> 24. Legal Issues< BR> 25. Billing and Reimbursement< BR> < BR> Section III: Clinical Informatics and IT Infrastructure< BR> 26. Cloud Computing for Clinical NGS Testing< BR> < BR> Section III: Interpretation< BR> 27. Bioinformatics of Long Read Sequencing< BR> < BR> Section IV: Regulation, Reimbursement, and Legal Issues< BR> 28. Business aspect of Precision Genomic Medicine< BR> 29. Driving precision medicine through genomics-EHR integration